alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Topics › drug-repurposing

drug-repurposing

2 studies tagged drug-repurposing, dated 2020-01-01 to 2025-02-11. Bibliography: BibTeX (.bib) · RIS (.ris)

Newest in this topic

  1. Population-Based Validation Results From the Drug Repurposing for Effective Alzheimer's Medicines (DREAM) Study 2025-02-11
  2. Recent Trends in the Management of Alzheimer's Disease: Current Therapeutic Options and Drug Repurposing Approaches 2020-01-01

Studies

2 studies carry this tag.

Date range

2020 to 2025

Top journals

  • Clinical pharmacology and therapeutics 1
  • Current neuropharmacology 1

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Population-Based Validation Results From the Drug Repurposing for Effective Alzheimer's Medicines (DREAM) Study

    ✓ Peer-reviewed alzhub usefulness score 57 out of 100. Clinical pharmacology and therapeutics 2025-02-11 Drug development

    We evaluated whether drugs approved for other indications that also target metabolic drivers of Alzheimer's disease and related dementia (ADRD) pathogenesis are associated with delayed onset of ADRD.

  2. Recent Trends in the Management of Alzheimer's Disease: Current Therapeutic Options and Drug Repurposing Approaches

    ✓ Peer-reviewed alzhub usefulness score 41 out of 100. Current neuropharmacology 2020-01-01 Drug development

    Alzheimer's disease is one of the most progressive forms of dementia, ultimately leading to death in aged populations.

All topic tags with their study counts